CClinicalTrials.gg
RecruitingNCT07610109Updated May 27, 2026

Effects of Comprehensive Community Support Programs on Cognitive Function and Quality of Life in Older Adults

An observational study in Cognitive Decline, Aging and Quality of Life, sponsored by Istanbul Medipol University Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-05-27.

Sponsored by Istanbul Medipol University Hospital · Observational

From the registry’s dates

  • Started May 2026; still recruiting 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
60 Years and older
Sex
All
01

Study summary

This prospective observational study aims to investigate the effects of a multidomain community-based support program on cognitive function and quality of life in older adults attending the Vefahane Life Center in Istanbul, Türkiye. The study will compare elderly individuals actively participating in community-based social, cognitive, physical, and supportive activities with individuals registered at the center but not actively participating during the study period. Participants will undergo neuropsychological and psychosocial assessments at baseline and after 3 months. The primary outcome is change in global cognitive performance measured by the Mini Mental State Examination (MMSE). Secondary outcomes include memory, executive functions, depression, neuropsychiatric symptoms, and quality of life measures.

Read the detailed description

Dementia is a growing global public health concern associated with aging populations worldwide. Recent evidence suggests that multidomain lifestyle interventions targeting modifiable risk factors may help preserve cognitive function and reduce dementia risk in older adults. Community-based support programs that combine cognitive, physical, social, and supportive activities may provide sustainable and culturally adaptable approaches for healthy aging.

This prospective non-interventional observational study aims to evaluate the effects of the Vefahane Life Center multidomain support model on cognitive functions and quality of life in older adults aged 60 years and above. The study will be conducted in elderly individuals registered at the Vefahane Life Center in Bağcılar, Istanbul.

Participants actively attending center-based activities will constitute the intervention/exposure group, while individuals registered at the center but not actively participating during the study period will serve as controls. Assessments will be performed at baseline and after 3 months.

The multidomain program includes social, cognitive, physical, cultural, artistic, educational, and supportive services tailored to individual preferences. Available activities include handicrafts, music, painting, physical exercise, cognitive games, language courses, hobby workshops, and psychosocial support services.

Cognitive and psychosocial outcomes will be evaluated using standardized instruments including the Mini Mental State Examination (MMSE), Subjective Memory Complaints Questionnaire (SMCQ), Trail Making Test (A+B), Verbal Memory Processes Test, Clock Drawing Test, Boston Naming Test, Neuropsychiatric Inventory (NPI), Quality of Life in Alzheimer's Disease Scale (QOL-AD), Geriatric Depression Scale (GDS), Clinical Dementia Rating Scale (CDR), and CAIDE dementia risk assessment.

The primary objective of the study is to investigate changes in global cognitive performance. Secondary objectives include evaluation of memory, executive functions, depressive symptoms, neuropsychiatric symptoms, and quality of life outcomes associated with participation in the multidomain community support program.

The study is considered minimal risk because it involves non-invasive assessments and routine community-based activities.

02

Conditions studied

  • Cognitive Decline
  • Aging
  • Quality of Life

Keywords

  • older adults
  • aging
  • cognitive rehabilitation
  • cognitive function
  • community-based intervention
  • social wellbeing
  • social participation
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 120 is below the median of 150 across 950 observational studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Istanbul Medipol University Hospital is the lead sponsor of 350 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Community-dwelling older adults aged 60 years and above registered at the Vefahane Life Center in Bağcılar, Istanbul, Türkiye. Participants include individuals actively participating in multidomain community-based activities and age-compatible individuals registered at the center but not actively participating during the study period.

Inclusion criteria

  • Elderly individuals aged 60 and over who attend or will attend Vefahane Life Center
  • Able to cooperate,
  • Individuals who speak Turkish
  • Individuals who are literate

Exclusion criteria

Exclusion Criteria:

  • Individuals previously diagnosed with dementia,

    • Individuals with neurological and psychiatric diagnoses that affect cognitive skills,
    • Individuals receiving occupational therapy interventions aimed at improving cognitive skills within the center,
    • Individuals with illnesses that prevent participation in the activity program (cancer, cardiovascular instability, etc.),
    • Individuals with severe visual and hearing loss that hinders communication.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Active Participation Group

    Older adults actively participating in multidomain community-based activities and supportive services provided at the Vefahane Life Center.

    Behavioral: Multidomain Community Support Program

  • Non-Participating Control Group

    Older adults registered at the Vefahane Life Center but not actively participating in the available activities during the study period.

Interventions

  • BehavioralMultidomain Community Support Program

    Participants in the exposure group will attend multidomain community-based activities and supportive services provided at the Vefahane Life Center according to their individual preferences. Available activities include cognitive, social, physical, cultural, artistic, educational, and supportive programs such as handicrafts, music, painting, physical exercise, cognitive games, language courses, hobby workshops, psychosocial support, occupational therapy, and counseling services. Participation frequency and attendance will be prospectively recorded throughout the study period.

06

What researchers measure

Primary outcomes

  1. Change in global cognitive performance measured by Mini Mental State Examination (MMSE)

    The primary outcome is the change in MMSE score between baseline and 3-month follow-up assessments in older adults participating in the multidomain community support program compared with controls.

    Time frame: Baseline and 3 months

07

Study locations

1 of 1 sites recruiting
  • Vefahane Life Center, Bagcilar Municipality
    Istanbul, Bagcılar, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07610109
Lead sponsor
Istanbul Medipol University Hospital
Collaborators
Vefahane Bağcılar
Responsible party
Prof. Lutfu Hanoglu, MD (Professor of Neurology, Istanbul Medipol University Hospital) — Principal investigator
First posted
May 27, 2026
Start date
May 20, 2026
Primary completion
Aug 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
May 27, 2026

Study contacts

Lütfü Hanoğlu
Contact
lhanoglu@kure.com.tr
905324868048

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion